CNS experienced massive revenue growth of 285% but simultaneously turned deeply cash flow negative, swinging from $96.7M positive to -$120.4M negative operating cash flow.
This dramatic divergence between revenue growth and cash flow performance suggests potential revenue recognition issues, significant changes in business model, or major working capital deterioration that requires immediate investor scrutiny. The combination of such extreme metrics indicates either a fundamental business transformation or potential financial reporting concerns.
CNS delivered explosive revenue growth of 285% to $427.5M, but this came at the cost of a catastrophic $217M negative swing in operating cash flow from positive $96.7M to negative $120.4M. Despite the cash flow deterioration, the company increased share buybacks by 35% to $28.4M while cash reserves declined 20% to $145.5M, suggesting management confidence but raising questions about capital allocation priorities given the operating cash flow crisis.
Strong top-line growth of 284.6% — accelerating demand or successful expansion into new markets.
Operating cash flow fell 224.6% — earnings quality concerns; investigate working capital changes and non-cash items.
Capex reduced 48.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Share repurchases increased 34.6% — management returning capital, signals confidence in intrinsic value.
Cash decreased 20.5% — monitor burn rate and upcoming capital needs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →